Prognostic impact of minimal residual disease in patients with early breast cancer (T1)

被引：0
|
作者：
Diel, IJ [1 ]
Solomayer, EF [1 ]
Gollan, C [1 ]
Wallwiener, D [1 ]
Bastert, G [1 ]
机构：
[1] UNIV HEIDELBERG,DEPT OB GYN,HEIDELBERG,GERMANY
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：340 / 340
页数：1
相关论文
共 50 条
  • [31] Prognostic significance of tumour size in T1 breast cancer patients and postmenopausal status:: Analysis of 1580 patients
    Fiorio, E.
    Auriemma, A.
    Mercanti, A.
    Mandara, M.
    Caldara, A.
    Pavarana, M.
    Micciolo, R.
    Cetto, G. L.
    Molino, A.
    ANNALS OF ONCOLOGY, 2006, 17 : XI5 - XI5
  • [32] The prognostic factors of breast cancer related with axillary lymph node metastasis in T1 breast cancer
    Gwak, G.
    Park, K.
    Han, S.
    Kim, K.
    Kim, H.
    Kim, Y.
    Kim, H.
    Kim, K.
    Bae, B.
    Yang, K.
    EJC SUPPLEMENTS, 2010, 8 (03): : 171 - 172
  • [33] Prognostic implication of early minimal residual disease evaluation in patients with chronic myelomonocytic leukemia
    Wang, Lulu
    Chen, Rongrong
    Li, Li
    Zhu, Lixia
    Huang, Xianbo
    Ye, Xiujin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (05): : 2216 - 2225
  • [34] PROGNOSTIC IMPACT OF MINIMAL RESIDUAL DISEASE PRETRANSPLANT ALLOGENEIC IN PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA
    Perez Lopez, O.
    Caballero Velazquez, T.
    Gonzalez Campos, J.
    Rodriguez Torres, N.
    Prats Martin, C.
    Vargas de los Monteros, M. T.
    Perez Simon, J. A.
    HAEMATOLOGICA, 2017, 102 : 172 - 173
  • [35] Axillary invasion in T1 Breast Cancer premenopausal patients
    Pais, A. S.
    Subtil, S.
    Ramalho, I.
    Dias, M. Figueiredo
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 276 - 276
  • [36] Predicting nodal status in patients with T1 breast cancer
    Harden, SP
    Neal, A
    Al-Nasiri, N
    Ashley, S
    della Rovere, GQ
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S47 - S47
  • [37] Prognostic impact of minimal residual disease on outcome in the SORMAIN trial
    Burchert, A.
    Bug, G.
    Finke, J.
    Stelljes, M.
    Roellig, C.
    Wollmer, E.
    Waesch, R.
    Bornhaeuser, M.
    Berg, T.
    Lang, F.
    Ehninger, G.
    Serve, H.
    Zeiser, R.
    Wagner, E. -M.
    Kroeger, N.
    Wolschke, C.
    Schleuning, M.
    Goetze, K.
    Schmid, C.
    Crysandt, M.
    Esseling, E.
    Wolf, D.
    Wang, Y.
    Boehm, A.
    Thiede, C.
    Haferlach, T.
    Michel, C.
    Bethge, W.
    Wuendisch, T.
    Brandts, C.
    Harnisch, S.
    Wittenberg, M.
    Hoeffkes, H. -G.
    Rospleszcz, S.
    Burchardt, A.
    Neubauer, A.
    Brugger, M.
    Strauch, K.
    Schade-Brittinger, C.
    Metzelder, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 16 - 16
  • [38] ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease
    Stecklein, Shane R.
    Kimler, Bruce F.
    Yoder, Rachel
    Schwensen, Kelsey
    Staley, Joshua M.
    Khan, Qamar J.
    O'Dea, Anne P.
    Nye, Lauren E.
    Elia, Manana
    Heldstab, Jaimie
    Home, Trisha
    Hyter, Stephen
    Isakova, Kamilla
    Pathak, Harsh B.
    Godwin, Andrew K.
    Sharma, Priyanka
    NPJ BREAST CANCER, 2023, 9 (01)
  • [39] ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease
    Shane R. Stecklein
    Bruce F. Kimler
    Rachel Yoder
    Kelsey Schwensen
    Joshua M. Staley
    Qamar J. Khan
    Anne P. O’Dea
    Lauren E. Nye
    Manana Elia
    Jaimie Heldstab
    Trisha Home
    Stephen Hyter
    Kamilla Isakova
    Harsh B. Pathak
    Andrew K. Godwin
    Priyanka Sharma
    npj Breast Cancer, 9
  • [40] Clinical validation of ctDNA profiling for detecting early-stage breast cancer patients with minimal residual disease
    Fujimoto, Yuri
    Kawashima, Masahiro
    Derek, Dustin
    Ohhashi, Yu
    Pu, Fengling
    Kawaguchi, Kosuke
    Toi, Masakazu
    CANCER SCIENCE, 2024, 115 : 1579 - 1579
12345